Business Wire

Neustar: DDoS Attacks Increase 180% in 2019 Compared To 2018

26.3.2020 11:00:00 EET | Business Wire | Press release

Share

Neustar, Inc., a global information services and technology company and leader in identity resolution, announced that its Security Operations Center (SOC) saw a 168% increase in distributed denial-of-service (DDoS) attacks in Q4 2019, compared with Q4 2018, and a 180% increase overall in 2019 vs. 2018. According to Neustar’s latest cyber threats and trends report, released today, the company saw DDoS attacks across all size categories increase in 2019, with attacks sized 5 Gbps and below seeing the largest growth. These small-scale attacks made up more than three quarters of all attacks the company mitigated on behalf of its customers in 2019.

DDoS attacks taking varied forms
In 2019, the largest threat Neustar mitigated, at 587 gigabits per second (Gbps), was 31% larger than the largest attack of 2018, while the maximum attack intensity observed in 2019, 343 million packets per second (Mpps), was 252% higher than that of the most intense attack seen in 2018. However, despite these higher peaks, the average attack size (12 Gbps) and intensity (3 Mpps) remained consistent year over year. The longest single, uninterrupted attack experienced in 2019 lasted three days, 13 hours and eight minutes.

Though the number of attacks increased significantly across all size categories, small-scale attacks (5 Gbps and below) again saw the largest growth in 2019, continuing the trend from the previous year. The combination of DDoS-for-hire and botnet rental services has made DDoS attacks much easier to execute, but the fact that perpetrators seem to be in many cases choosing to engage in small-scale attacks suggests that their goal may often be something other than taking a site completely offline.

“Large, headline-making DDoS attacks do still take place, but many cybersecurity professionals believe that smaller attacks are being used simply to degrade site performance or as a smokescreen for other forms of cybercrime, such as data theft or network infiltration, which the perpetrator can execute more easily while the target’s security team is busy fighting a DDoS attack,” said Rodney Joffe, senior vice president, senior technologist and fellow at Neustar. “Furthermore, with the current move of the bulk of the workforce globally to a work from home model, we expect to see a significant increase in DDoS attacks against VPN infrastructure. This risk makes an ‘always on’ DDoS mitigation service even more critical.”

In addition to conventional DDoS attacks, which seek to exhaust bandwidth, in 2019 Neustar also observed an increase in network protocol or state exhaustion attacks, which target network infrastructure directly. Volumetric attacks continued to proliferate as well, with attackers using new DDoS vectors such as Apple Remote Management Services, Web Services Dynamic Discovery, Ubiquiti Discovery Protocol and the Constrained Application Protocol.

Said Joffe, “During the shift to teleworking at scale, we would not be surprised to see the VPN protocol ports added to these targeted attacks.”

Two- and three-vector attacks ‘just right’ for attackers
In 2019, approximately 85% of all attacks used two or more threat vectors. That number is comparable to the 2018 figure; however, the number of attacks involving two or three vectors rose from 55% to 70%, with correspondingly fewer simple single-vector attacks and complex four- and five-vector attacks, suggesting that attackers have settled into the Goldilocks zone for attacks.

Security professionals continue to view DDoS attacks as a growing threat. According to the most recent Neustar International Security Council (NISC) survey, when asked which vectors they perceived to be increasing threats during November and December 2019, senior-level cybersecurity decision-makers cited social engineering via email most frequently (59%), followed by DDoS (58%) and ransomware (56%).

Web attacks increasing
2019 saw web attacks on the rise as well. Most companies recognise the danger that slow-loading websites pose to their business and attempt to protect them with web application firewalls. In the most recent NISC survey, 98% of respondents agreed that a WAF was an essential component of their security infrastructure. However, as more and more enterprises use multiple cloud providers, often involving a mix of public and private clouds, the need for consistent security across applications and platforms is growing.

“Web attacks can be difficult to track because some variation in the performance of websites is to be expected, but they are increasingly critical for businesses to address. One survey found 45% of consumers are less likely to make a purchase when they experience a slow loading website, and 37% are less likely to return to a retailer if they experience slow loading pages,” added Joffe.

A vendor-neutral cloud WAF, coupled with DDoS protection, can eliminate a large portion of threats, allowing enterprise application experts to focus their attention on the more specialised attacks. Continuous updates from a reliable threat feed can also deliver information on bad IPs and botnet command and control (C&C) sites before they are able to damage the network.

A complimentary copy of the Neustar 2019: The Year in Review cyber threats and trends report is available here.

-ENDS-

About Neustar
Neustar is an information services and technology company and a leader in identity resolution providing the data and technology that enables trusted connections between companies and people at the moments that matter most. Neustar offers industry-leading solutions in Marketing, Risk, Communications, Security and Registry that responsibly connect data on people, devices and locations, continuously corroborated through billions of transactions. Neustar serves more than 8,000 clients worldwide, including 60 of the Fortune 100. Learn how your company can benefit from the power of trusted connections here: https://www.home.neustar.

# # #

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Jenny Morris
Hotwire for Neustar
+44 (0)7393465529
neustaruk@hotwireglobal.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye